Adverse Drug Reactions
ASPS Addresses Concerns Regarding BOTOX Treatments
Published in Medical Letter on the CDC and FDA, February 17th, 2008
On January 23, Public Citizen requested the U.S. Food and Drug Administration (FDA) implement labeling changes and a written communication to physicians.
More than one million people have been treated with BOTOX Cosmetic. Complications and adverse events from BOTOX Cosmetic treatments are rare.
"As patient advocates, plastic surgeons are primarily concerned about the safety of our patients," said Richard A. D'Amico, MD, ASPS president. "We have...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Bipolar Disorder
Scientists at Harvard University target bipolar disorder - Combination Therapy
MIGENIX to Add 600mg Daily Celgosivir Dose to Phase II Viral Kinetics Study - HIV/AIDS
Reports summarize HIV/AIDS study results from B.M. Branson and co-researchers - Regulatory Actions
Cepheid Receives Health Canada Medical Device License for Xpert MRSA(TM) Test and GeneXpert(R) System - Weight Loss
Study data from Midwestern University update knowledge of weight loss - Life Sciences
Studies from University of Colorado, National Jewish Medical and Research Center update current data on life sciences - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
